Français
ItalianoBond Novartis AG 0% ( US66989HBD98 ) in USD
| Issuer | Novartis AG | ||||||
| Market price |  100.00 % ⇌ |
||||||
| Country |  Switzerland
|
||||||
| ISIN code |
 US66989HBD98 ( in USD )
|
||||||
| Interest rate | 0% | ||||||
| Maturity | 05/11/2028 | ||||||
|
Prospectus brochure in PDF format |
|||||||
| Minimal amount | / | ||||||
| Total amount | / | ||||||
| Cusip | 66989HBD9 | ||||||
| Standard & Poor's ( S&P ) rating | AA- ( High grade - Investment-grade ) | ||||||
| Moody's rating | Aa3 ( High grade - Investment-grade ) | ||||||
| Detailed description |
Novartis AG is a Swiss multinational pharmaceutical company that researches, develops, manufactures, and markets a broad range of innovative medicines and healthcare solutions globally. The Bond issued by Novartis AG ( Switzerland ) , in USD, with the ISIN code US66989HBD98, pays a coupon of 0% per year. The coupons are paid 2 times per year and the Bond maturity is 05/11/2028 The Bond issued by Novartis AG ( Switzerland ) , in USD, with the ISIN code US66989HBD98, was rated Aa3 ( High grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Novartis AG ( Switzerland ) , in USD, with the ISIN code US66989HBD98, was rated AA- ( High grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||
| |||||||